These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 18515844)
1. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model. Miyake T; Aoki M; Morishita R Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361 [TBL] [Abstract][Full Text] [Related]
3. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002 [TBL] [Abstract][Full Text] [Related]
5. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia. Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282 [TBL] [Abstract][Full Text] [Related]
6. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model. Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373 [TBL] [Abstract][Full Text] [Related]
7. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat. Han W; Liu GN Life Sci; 2010 Feb; 86(7-8):234-43. PubMed ID: 20025889 [TBL] [Abstract][Full Text] [Related]
8. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Hashiya N; Aoki M; Tachibana K; Taniyama Y; Yamasaki K; Hiraoka K; Makino H; Yasufumi K; Ogihara T; Morishita R Biochem Biophys Res Commun; 2004 Apr; 317(2):508-14. PubMed ID: 15063786 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880 [TBL] [Abstract][Full Text] [Related]
10. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits. Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759 [TBL] [Abstract][Full Text] [Related]
12. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits. Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949 [TBL] [Abstract][Full Text] [Related]
13. [Effects of nuclear factor-kappaB decoy oligodeoxynucleotide on the function of human umbilical artery smooth muscle cells induced by umbilical sera in preeclampsia]. Jiang RZ; Huang YJ; Gu JH; Mu WH; Chen HP Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):87-91. PubMed ID: 17442180 [TBL] [Abstract][Full Text] [Related]
15. PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
16. E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft. Cho WH; Lee SO; Kim HT; Ahn JD; Lee IK Transplant Proc; 2005; 37(1):77-9. PubMed ID: 15808553 [TBL] [Abstract][Full Text] [Related]
17. [Inhibition on phenotypic transformation of detrusor smooth muscle cells after bladder outlet obstruction by E2F decoy strategy]. Gong Y; Du CJ; Ding LL; Song B; Jin XY Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):829-32. PubMed ID: 17565867 [TBL] [Abstract][Full Text] [Related]
18. The role of ex-vivo gene therapy of vein grafts with Egr-1 decoy in the suppression of intimal hyperplasia. Peroulis M; Kakisis J; Kapelouzou A; Giagini A; Giaglis S; Mantziaras G; Kostomitsopoulos N; Karayannacos P; Macheras A Eur J Vasc Endovasc Surg; 2010 Aug; 40(2):216-23. PubMed ID: 20537569 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of neointimal hyperplasia after balloon injury by cis-element 'decoy' of early growth response gene-1 in hypercholesterolemic rabbits. Ohtani K; Egashira K; Usui M; Ishibashi M; Hiasa KI; Zhao Q; Aoki M; Kaneda Y; Morishita R; Takeshita A Gene Ther; 2004 Jan; 11(2):126-32. PubMed ID: 14712296 [TBL] [Abstract][Full Text] [Related]
20. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide. Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]